These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12173322)

  • 1. Adherence to repeat screening flexible sigmoidoscopy in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
    Weissfeld JL; Ling BS; Schoen RE; Bresalier RS; Riley T; Prorok PC;
    Cancer; 2002 May; 94(10):2569-76. PubMed ID: 12173322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acceptability of two colorectal cancer screening tests: pain as a key determinant in sigmoidoscopy.
    Kirkøen B; Berstad P; Botteri E; Dalén E; Nilsen JA; Hoff G; de Lange T; Bernklev T
    Endoscopy; 2017 Nov; 49(11):1075-1086. PubMed ID: 28938500
    [No Abstract]   [Full Text] [Related]  

  • 3. Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial.
    Weissfeld JL; Schoen RE; Pinsky PF; Bresalier RS; Church T; Yurgalevitch S; Austin JH; Prorok PC; Gohagan JK;
    J Natl Cancer Inst; 2005 Jul; 97(13):989-97. PubMed ID: 15998952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flexible sigmoidoscopy in the randomized prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial: added yield from a second screening examination.
    Weissfeld JL; Schoen RE; Pinsky PF; Bresalier RS; Doria-Rose VP; Laiyemo AO; Church T; Yokochi LA; Yurgalevitch S; Rathmell J; Andriole GL; Buys S; Crawford ED; Fouad M; Isaacs C; Lamerato L; Reding D; Prorok PC; Berg CD;
    J Natl Cancer Inst; 2012 Feb; 104(4):280-9. PubMed ID: 22298838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occurrence of Distal Colorectal Neoplasia Among Whites and Blacks Following Negative Flexible Sigmoidoscopy: An Analysis of PLCO Trial.
    Laiyemo AO; Doubeni C; Pinsky PF; Doria-Rose VP; Bresalier R; Hickey T; Riley T; Church TR; Weissfeld J; Schoen RE; Marcus PM; Prorok PC
    J Gen Intern Med; 2015 Oct; 30(10):1447-53. PubMed ID: 25835747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status.
    Gohagan JK; Prorok PC; Hayes RB; Kramer BS;
    Control Clin Trials; 2000 Dec; 21(6 Suppl):251S-272S. PubMed ID: 11189683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overall and Multiphasic Findings of the Prostate, Lung, Colorectal and Ovarian (PLCO) Randomized Cancer Screening Trial.
    Prorok PC; Wright P; Riley TR; Kramer BS; Berg CD; Gohagan JK
    Rev Recent Clin Trials; 2018; 13(4):257-273. PubMed ID: 29629665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.
    Prorok PC; Andriole GL; Bresalier RS; Buys SS; Chia D; Crawford ED; Fogel R; Gelmann EP; Gilbert F; Hasson MA; Hayes RB; Johnson CC; Mandel JS; Oberman A; O'Brien B; Oken MM; Rafla S; Reding D; Rutt W; Weissfeld JL; Yokochi L; Gohagan JK;
    Control Clin Trials; 2000 Dec; 21(6 Suppl):273S-309S. PubMed ID: 11189684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: long-term follow-up of the randomised US PLCO cancer screening trial.
    Miller EA; Pinsky PF; Schoen RE; Prorok PC; Church TR
    Lancet Gastroenterol Hepatol; 2019 Feb; 4(2):101-110. PubMed ID: 30502933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality control of cancer screening examination procedures in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.
    Weissfeld JL; Fagerstrom RM; O'Brien B;
    Control Clin Trials; 2000 Dec; 21(6 Suppl):390S-399S. PubMed ID: 11189690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Is flexible sigmoidoscopy as preventive measure for colorectal carcinoma in asymptomatic patients over 45 practicable?].
    Rüttimann S; Bonetti P; Beglinger C; Loosli J; Meyer-Wyss B; Stalder GA; Dubach UC
    Schweiz Med Wochenschr; 1992 May; 122(19):742-4. PubMed ID: 1594910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of flexible sigmoidoscopy screening in men and women and different age groups: pooled analysis of randomised trials.
    Holme Ø; Schoen RE; Senore C; Segnan N; Hoff G; Løberg M; Bretthauer M; Adami HO; Kalager M
    BMJ; 2017 Jan; 356():i6673. PubMed ID: 28087510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Nonadherence to Cancer Screening Examinations With Mortality From Unrelated Causes: A Secondary Analysis of the PLCO Cancer Screening Trial.
    Pierre-Victor D; Pinsky PF
    JAMA Intern Med; 2019 Feb; 179(2):196-203. PubMed ID: 30592477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acceptance of flexible sigmoidoscopy as a screening examination for colorectal cancer in an outpatient clinic.
    Gölder S; Vogt W; Lichti H; Rath HC; Kullmann A; Schölmerich J; Kullmann F
    Int J Colorectal Dis; 2007 Apr; 22(4):387-94. PubMed ID: 16819639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cumulative incidence of false-positive results in repeated, multimodal cancer screening.
    Croswell JM; Kramer BS; Kreimer AR; Prorok PC; Xu JL; Baker SG; Fagerstrom R; Riley TL; Clapp JD; Berg CD; Gohagan JK; Andriole GL; Chia D; Church TR; Crawford ED; Fouad MN; Gelmann EP; Lamerato L; Reding DJ; Schoen RE
    Ann Fam Med; 2009; 7(3):212-22. PubMed ID: 19433838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early detection versus primary prevention in the PLCO flexible sigmoidoscopy screening trial: Which has the greatest impact on mortality?
    Doroudi M; Schoen RE; Pinsky PF
    Cancer; 2017 Dec; 123(24):4815-4822. PubMed ID: 28976536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of repeat sigmoidoscopy 3 years after a negative examination.
    Schoen RE; Pinsky PF; Weissfeld JL; Bresalier RS; Church T; Prorok P; Gohagan JK;
    JAMA; 2003 Jul; 290(1):41-8. PubMed ID: 12837710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial.
    Andriole GL; Levin DL; Crawford ED; Gelmann EP; Pinsky PF; Chia D; Kramer BS; Reding D; Church TR; Grubb RL; Izmirlian G; Ragard LR; Clapp JD; Prorok PC; Gohagan JK;
    J Natl Cancer Inst; 2005 Mar; 97(6):433-8. PubMed ID: 15770007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing contamination and compliance in the prostate component of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
    Pinsky PF; Blacka A; Kramer BS; Miller A; Prorok PC; Berg C
    Clin Trials; 2010 Aug; 7(4):303-11. PubMed ID: 20571134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk-stratified screening and colorectal cancer incidence and mortality: A retrospective study from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
    Zhang Y; Sheng C; Fan Z; Liu Y; Liu X; Duan H; Dai H; Lyu Z; Yang L; Song F; Song F; Huang Y; Chen K
    Prev Med; 2024 Oct; 187():108117. PubMed ID: 39178994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.